Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention
NCT05834712 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 224
Last updated 2025-01-27
Summary
To study the difference in the proportion of patients with nasopharyngeal carcinoma who lost more than 10% of their body weight within 1 month after radiotherapy and chemotherapy using the mobile platform for whole-process individualized nutritional rehabilitation management compared with conventional nutritional rehabilitation management.
Conditions
- Nasopharyngeal Carcinoma
Interventions
- DEVICE
-
mobile platform or not mobile platform
Intervention using WeChat
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-11
- Primary Completion
- 2023-09-24
- Completion
- 2024-09-24
Countries
- China
Study Locations
More Related Trials
-
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT05780372 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy
NCT04384627 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Individualized Elective Neck Irradiation Based on MRI in NPC Patients
NCT02642107 ·Status: COMPLETED ·Phase: PHASE3
-
Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03919552 ·Status: RECRUITING ·Phase: PHASE3
-
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
NCT04472403 ·Status: UNKNOWN
-
Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma
NCT04823468 ·Status: COMPLETED ·Phase: NA
-
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03047265 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
NCT07188584 ·Status: RECRUITING ·Phase: PHASE3
-
Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma
NCT03668730 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT02434614 ·Status: UNKNOWN ·Phase: PHASE3
-
Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT04136886 ·Status: RECRUITING ·Phase: PHASE3
-
A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma
NCT07062484 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
NCT02627807 ·Status: UNKNOWN ·Phase: NA
-
Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients
NCT02604472 ·Status: COMPLETED
-
Nedaplatin in Treatment for Nasopharyngeal Carcinoma
NCT04834206 ·Status: COMPLETED ·Phase: PHASE2
-
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma
NCT04764149 ·Status: UNKNOWN
-
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
NCT06239727 ·Status: RECRUITING ·Phase: PHASE3
-
Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma
NCT01540136 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Randomized Controlled Clinical Study on the Treatment of T3N1M0 High Risk Nasopharyngeal Carcinoma With or Without Induction Chemotherapy Before Concurrent Radiotherapy and Chemotherapy
NCT05622474 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC
NCT07235319 ·Status: RECRUITING ·Phase: PHASE3
-
Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain
NCT05304468 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
NCT03503136 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients
NCT04061278 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT01479504 ·Status: UNKNOWN ·Phase: PHASE3
-
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05340270 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2